GGrantIndex
Sort

78,016 grants matching breast cancer

Genetic Susceptibility And The Environment In Cancer Risk

$687,151
Jack A Taylor · National Institute Of Environmental Health Sciences · ZIA · FY2019 · ES

A Randomized Trial to Minimize Non-Response to Aerobic Training in Operable Breast Cancer

$687,076
Jessica Scott · Sloan-Kettering Inst Can Research · R37 · FY2023 · CA

Electronic health record (EHR)-based implementation strategies and decision support for hereditary breast and ovarian cancer (HBOC) genetic testing among multiethnic women (ELISABETH)

$686,993
Katherine D Crew · Columbia University Health Sciences · UG3 · FY2025 · CA

Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research

$686,990
Rebecca S Crowley · University Of Pittsburgh At Pittsburgh · U24 · FY2013 · CA

Flexible versus Standard Aerobic Training Dosing in Primary Breast Cancer: A Randomized and Response-Adapted Trial

$686,954
Jessica Scott · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA

RCT of Primary Care-based Patient Navigation-Activation

$686,951
Kevin Fiscella · University Of Rochester · U01 · FY2009 · CA

HYBRID, FLAT-PANEL, ACTIVE MATRIX MAMMOGRAPHIC IMAGER

$686,895
University Of Michigan At Ann Arbor · R01 · FY2001 · CA

Mechanisms of fibrosis and lymphatic dysfunction in post-surgical lymphedema

$686,863
Babak J Mehrara · Sloan-Kettering Inst Can Research · R01 · FY2016 · HL

Mechanistic studies of hirsutinolides and azetidine-based small molecule inhibitors of STAT3

$686,846
James K Turkson · Cedars-Sinai Medical Center · R01 · FY2025 · CA

Could Dedicated Breast PET Predict Multifocality?

$686,822
Naviscan Pet Systems, Inc. · R44 · FY2005 · CA

Genomic Basis of Reproductive History on Breast Cancer

$686,815
Fox Chase Cancer Center · R01 · FY2005 · CA

BLIMP-1 mediated regulation of CD8+ TIL

$686,810
Timothy N Bullock · University Of Virginia · R01 · FY2016 · CA

BLIMP-1 mediated regulation of CD8+ TIL

$686,810
Timothy N Bullock · University Of Virginia · R01 · FY2017 · CA

Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish

$686,787
Leanna J Standish · Bastyr University · U19 · FY2013 · AT

Impact of exercise on ovarian cancer prognosis

$686,732
Melinda L Irwin · Yale University · R01 · FY2009 · CA

Interaction of Chemical Carcinogens and Chemotherapeutic Agents with DNA

$686,710
Miriam C Poirier · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA

Genetic Epidemiology of Telomere Maintenance and Cancer Etiology

$686,710
Sharon A. Savage · Division Of Cancer Epidemiology And Genetics · ZIA · FY2015 · CA

Acylcarnitine Metabolism in Ovarian Cancer Chemoresistance

$686,654
Katherine Marie Aird · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · CA

Older Breast Cancer Patients: Risk For Cognitive Decline

$686,651
Jeanne Mandelblatt · Georgetown University · R01 · FY2019 · CA

Clinical breast cancer risk prediction models for women with a high-risk benign breast diagnosis

$686,647
Brian L Sprague · University Of Vermont & St Agric College · R01 · FY2024 · CA

Spectro-Holographic Instrument for Dynamic Sensing of Cancer Progression

$686,599
Lev T. Perelman · Beth Israel Deaconess Medical Center · R01 · FY2022 · CA

Optoacoustic imaging enhanced by gold nanorods

$686,552
Alexander A Oraevsky · Fairway Medical Technologies, Inc. · R44 · FY2007 · CA

Functional Analysis of Breast Cancer Susceptibility Genes in Mice

$686,490
Shyam Sharan · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

GENETICALLY ENCODED, TARGETED, AMPLIFIABLE, IMAGING AGENTS FOR THE EARLY DETECTION OF BREAST CANCER

$686,480
Rector & Visitors Of The University Of Virginia · · FY2008 · Department of the Army

EXERCISE, DIET, AND SEX HORMONES IN POSTMENOPAUSAL WOMEN

$686,454
Fred Hutchinson Cancer Research Center · R01 · FY2005 · CA